Philippe Saiag

11PUBLICATIONS
78CO-AUTHORS
Tumour immunologyNanomedicineRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan, Miso Kim, Ignacio Mendez

|Jun 27, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag

|Jun 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.

Robin Zagala, Stephane Dalle, Marie Beylot-Barry

|Jan 26, 2024
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.

Marie Bellouard, Jean Donadieu, Pauline Thiebot

|Jul 29, 2023
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo

|Dec 08, 2022
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.

James S Wilmott, Hussein Tawbi, Johnathan A Engh

Pageof 2

Frequent Collaborators

3 joint publications

Caroline Robert

2 joint publications

C Longvert

2 joint publications

Thomas Jouary

2 joint publications

E Funck-Brentano